Molecular Microbiology (2009) 74(3), 529â€“540 äŠ?                                               doi:10.1111/j.1365-2958.2009.06761.x
                                                                                              published online 24 June 2009



Dissecting essentiality bifunctional trypanothione
synthetase-amidase Trypanosoma brucei using chemical genetic methods                          mmi_6761 529..540




Susan Wyllie, Sandra L. Oza, Stephen Patterson,                    Introduction
Daniel Spinks, Stephen Thompson Alan H. Fairlamb*                                                  protozoan parasite Trypanosoma brucei caus-
Division Biological Chemistry Drug Discovery,               ative agent human African trypanosomiasis (HAT),
Wellcome Trust Biocentre, College Life Sciences,                commonly known sleeping sickness. disease,
University Dundee, Dundee, DD1 5EH, Scotland, UK.               thought largely controlled 1960s,                                                                    emerged major threat human health                                                                    number factors including lack financial resources,
Summary                                                            conflict affected countries failure adequately
                                                                   monitor infection. Currently, World Health Organisa- bifunctional trypanothione synthetase-amidase
                                                                   tion reports 400 000 people infected (TRYS) comprises structurally distinct catalytic
                                                                   HAT, resulting annual death toll domains synthesis hydrolysis trypan-
                                                                   50 000 (Stuart et al., 2008). absence effec-
othione (N 1,N 8-bis(glutathionyl)spermidine).                                                                    tive vaccine, treatment solely dependent piti-
unique dithiol plays pivotal role thiol-redox
                                                                   fully small repertoire drugs suffer homeostasis defence chemical                                                                    number problems including severe toxic effects
oxidative stress trypanosomatids. tetracycline-
                                                                   (Fairlamb, 2003) acquired drug resistance (Barrett
dependent conditional double knockout TRYS
                                                                   Fairlamb, 1999). compound difficulties,
(cDKO) generated bloodstream Trypanosoma
                                                                   current chemotherapeutic treatments brucei. Culture cDKO parasites tetracycline
                                                                   require lengthy periods hospitalization pro-
induction resulted loss trypanothione accu-
                                                                   hibitively expensive (Stuart et al., 2008). new
mulation glutathione, followed growth inhibition
                                                                   drugs treatment HAT pipeline,  cell lysis 6 days. absence inducer,
                                                                   certed effort identify, characterize cDKO cells unable infect mice, confirming                                                                    validate novel molecular targets urgently required enzyme essential virulence vivo                                                                    drug discovery. vitro. establish enzymatic functions
                                                                      search anti-parasitic drug targets, metabolic essential, amidase-dead mutant cDKO line
                                                                   pathways essential parasite survival generated. presence inducer, line
                                                                   absent host logical starting points (El
showed decreased growth vitro decreased viru-
                                                                   Sayed et al., 2005). pathway thiol
lence vivo, indicating amidase function                                                                    metabolism trypanosomes Leishmania. absolutely required viability. druggability
                                                                   parasites uniquely dependent trypanothione TRYS assessed using potent small molecule
                                                                   (N 1,N 8-bis(glutathionyl)spermidine, T[SH]2) prin-
inhibitor developed laboratory. Growth inhibi-
                                                                   cipal thiol, contrast organisms (including
tion correlated rank order cDKO, single KO, wild-
                                                                   mammalian hosts) utilize glutathione (g-L-
type overexpressing lines produced                                                                    glutamyl-L-cysteinylglycine, GSH) (Fairlamb et al., 1985).
predicted biochemical phenotype. synthetase
                                                                   dithiol primarily responsible maintenance
function TRYS unequivocally validated                                                                    thiol-redox homeostasis trypanosomatids, drug target chemical genetic methods.
                                                                   involved number critical cellular processes
                                                                   including deoxyribonucleotide synthesis (Dormeyer
Accepted 3 June, 2009.  correspondence. E-mail h.fairlamb@   et al., 2001), defence oxidative stress (Ariy-
dundee.ac.uk; Tel. (+44) 1382 38 5155; Fax (+44) 1382 38 5542.     anayagam Fairlamb, 2001) xenobiotics (Vickers use article permitted accordance Terms Conditions set http://www3.interscience.wiley.com/      et al., 2004). Trypanothione implicated
authorresources/onlineopen.html                                    mode action mechanism Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  530 S. Wyllie et al. äŠ?

resistance antimonial drugs Leishmania spp.                 Results discussion
(Mukhopadhyay et al., 1996; Wyllie et al., 2004; Croft
et al., 2006) defence chemical                 Generation TRYS conditional null mutants
oxidant stress induced arsenicals nifurtimox            date, essentiality T. brucei trypanothione syn-
T. brucei (Fairlamb et al., 1989; Ariyanayagam et al.,            thetase (TRYS) demonstrated RNAi
2005; Alibu et al., 2006).  attempt            (Comini et al., 2004; Ariyanayagam et al., 2005), meth-
exploit essential unique metabolite, T[SH]2-             odology lacks robustness classical gene
dependent biosynthetic enzymes                  replacement. mind, sought definitively
major focus drug discovery.                                   classify enzyme drug target bloodstream try-
   pivotal role T[SH]2 metabolism viability     panosomes replacing TRYS drug-resistance
virulence trypanosomatids unequivocally               genes (Fig. 1A). Previous studies demonstrated demonstrated using genetic techniques classical           TRYS present single-copy gene haploid
gene knockout RNA interference (RNAi).                        genome T. brucei (Oza et al., 2003). TRYS
Trypanothione-dependent enzymes vali-              gene copy replaced puromycin N-acetyl
dated potential drug targets using methodologies         transferase (PAC) gene homologous recombination
include: trypanothione reductase (Tovar et al., 1998;             subsequent selection puromycin resistance, gen-
Krieger et al., 2000), tryparedoxin (Wilkinson et al., 2003)      erating single knockout (SKO) cell line. Attempts tryparedoxin peroxidase (Wilkinson et al., 2003).             create null mutant directly replacing second
Unsurprisingly, enzyme responsible biosynthe-         allelic copy hygromycin-resistance gene (hygro-
sis T[SH]2, bifunctional trypanothione synthetase-         mycin phosphotransferase, HYG) proved unsuccessful,
amidase (TRYS), confirmed essential              suggesting TRYS essential viability viability proliferation T. brucei bloodstream      T. brucei bloodstream parasites. Consequently, 
(Comini et al., 2004) procyclic forms (Ariyanayagam           ditional double knockout (cDKO) cell line generated
et al., 2005) RNAi. pathogenic trypanosomatids,             introducing ectopic tetracycline-inducible copy
TRYS catalyses synthesis T[SH]2 GSH               TRYS prior replacing second copy HYG.
spermidine step, ATP-dependent reaction            ectopic copy TRYS inserted rDNA
glutathionylspermidine intermediate. addition          locus SKO cell line using pLew 100 vector encod-
role biosynthesis, N-terminal domain TRYS          ing blasticidin-resistance gene (BSD) followed dele-
functions amidase, hydrolysing T[SH]2 GSH            tion second genomic copy HYG. spermidine, glutathionylspermidine. bio-            modified T. brucei 427 cell line [wild-type (WT)] used logical significance TRYS-amidase, classified             study constitutively expresses T7 RNA poly-
cysteineâ€“histidine-dependent aminohydrolase/peptidase             merase tetracycline repressor protein, result-
amidase (Bateman Rawlings, 2003; Rigden et al.,               ing cell line TRYS conditional null mutant 2003), fully understood.  sug-         TRYS expression depends presence tetracy-
gested conflicting biosynthetic hydrolytic           cline (cDKO). Southern blot analysis genomic DNA
functions enzyme enable parasite               cell lines generated stage process
respond fluctuating cellular requirements             confirmed validity TRYS conditional null mutant
T[SH]2 polyamines, essential proliferation dif-       (Fig. 1B).
ferentiation (Fairlamb Cerami, 1992; Bacchi Yarlett, 1995).
                                                                  TRYS essential bloodstream T. brucei vitro
   current study, assessed essentiality TRYS classical gene replacement fulfil stringent        HMI9-T culture medium, significant difference target validation criteria University Dundee Drug       detected growth rates WT SKO
Discovery Unit (Frearson et al., 2007). Gene replacement          cells, generation times 9.6 â«¾ 0.1 9.5 â«¾ 0.2 h preferred method genetic validation             respectively (data shown).  cDKO cell line,
â€ targetâ€™ effects ruled using RNAi.         grown presence tetracycline, showed marked  target knock RNAi does permit inde-             growth phenotype doubling time 9.9 â«¾ 0.02 h
pendent analysis bifunctional enzymes                  (Fig. 2A). Following removal tetracycline DHFR-TS (Sienkiewicz et al., 2008) TRYS. Using               medium, cDKO cells continued grow exponentially combination classical gene replacement, mutagenesis            3 days. Growth slowed day 4 culture cells chemical intervention methods, dissect oppos-          finally dying day 8. determine actual point ing synthetic hydrolytic functions TRYS order        cDKO parasites grown absence tetracycline com-
independently study respective roles T. brucei cell      pletely lose viability, cells subcultured day virulence viability.                                          medium containing tetracycline. 6th day 
                                                                                                              Â© 2009 Authors
                                         Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
                                                                                                   Synthetase amidase activity TRYS essential 531

                               1st allele                                    cytostatic highly advantageous drug discovery
                      5â€²                              3â€²
                                    TRYS                                         perspective drug therapy dependent                                                                                fully functional immune response (Frearson et al., 2007).
                                         PAC

                                                                               Biochemical analyses TRYS cDKO cells
                                       500 bp
                                                                               â€˜slow deathâ€™ phenotype cDKO cells following                                     rDNA                                       removal tetracycline partly explained low
                              PARP
                                                                               turnover TRYS product, T[SH]2. Western blot
 ii                           Promoter                                         analysis cell extracts revealed                      T7       TetR                                             levels enzyme declined following removal                      Promoter Operator
             rDNA   BSD                        TRYS             rDNA           tetracycline, day 6 TRYS                                                                                longer detectable (Fig. 2B). observation suggests
                                                                               rate turnover TRYS  T[SH]2) low                                  2st allele
                                  TRYS                                         T. brucei TRYS  T[SH]2) removed  iii                                                                           cell dilution cell division absence                                        HYG                                     protein synthesis.  death                                                                                cDKO cells coinciding disappearance TRYS
                                                                               confirms enzyme essential  B             1          2        3           4                               bloodstream trypanosomes.
                                                                                  effect TRYS depletion intracellular thiols        kb                                                                      studied high-performance liquid chromatography
       12
                                                           ectopic TbTRYS      (HPLC). number cells required analy-
        7
        5
        4                                                                      sis, thiols monitored cultures 4 days
        3                                                  endogenous TbTRYS
                                                                               following removal tetracycline. cessation          2
       1.6                                                                     ectopic TRYS expression parasites                                                                                pronounced effect intracellular thiol levels (Fig. 2C).
                                                                               Glutathione, substrate TRYS, accumulated cDKO
Fig. 1. Genotypic analysis WT, SKO cDKO cell lines.                     cells absence tetracycline, 4 days,  Schematic representation stepwise generation TRYS cDKO cell line T. brucei.   allele TRYS                   levels reach 160  seen control cells
replaced puromycin-resistance gene (PAC) homologous                (cDKO cells plus tetracycline). contrast, T[SH]2 recombination, generating DTRYS::PAC cell line (SKO); (ii)                   glutathionylspermidine, products enzyme reac-
tetracycline-inducible ectopic copy TRYS introduced rDNA, generating TRYS TiDTRYS::PAC cell line; (iii)                      tion, fell considerably.  T[SH]2 levels tetracycline induces expression ectopic copy,                   parasites fell 16.5  control levels. 4 day cultures
remaining allele replaced hygromycin resistance gene                showed minimally retarded growth comparison
(HYG) homologous recombination, resulting conditional
double knockout cell line TRYS TiDTRYS::PAC/DTRYS::HYG                         control cells, appear bloodstream trypa-
(cDKO).                                                                        nosomes, vitro, survive vanishingly
B. Confirmation genotype T. brucei TRYS conditional double               small amounts T[SH]2.  noted knockout cell line. Southern blot analysis PstI-digested genomic
DNA (~5 mg) wild-type T. brucei cells (lane 1), DTRYS::PAC                HMI9-T culture medium used studies rich (lane 2), TRYS TiDTRYS::PAC (lane 3)                                       reducing agents thioglycerol (56 mM) cys-
TRYS TiDTRYS::PAC/DTRYS::HYG (lane 4) cells; TRYS ORF                      teine (1.5 mM) protect thiol-depleted
probe shows allelic TbTRYS 3 kb ectopic copy
TbTRYS Ti ~10 kb.                                                           cells oxidant stress.


                                                                               Virulence cDKO parasites mice
culture cells remained viable absence tetracy-
cline;  point viable cDKO cells                         oxidative environment vivo significantly different recovered culture 10 days.                           vitro culture conditions, underlining importance
Failure cell line grow absence                        carrying drug target validation studies appropri-
tetracycline-induced expression TRYS confirms                          ate animal models (Frearson et al., 2007). enzyme essential bloodstream T. brucei viability.                  mind, groups mice inoculated WT, cDKO Interestingly, ectopic expression L. major TRYS                         cDKO parasites grown absence equally capable complementing loss                           tetracycline 24 h. Mice infected tetracycline-
endogenous TRYS cDKO cell line (Fig. S1).                           treated parasites dosed doxycycline fact loss TRYS activity trypanocidal                    drinking water 5 days prior  infection 
Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
 532 S. Wyllie et al. äŠ?
                               1e11                                                          B
                                1e10
Cumulative cell numbers, ml-1


                                 1e9

                                 1e8
                                                                                              TRYS
                                 1e7

                                 1e6
                                                                                              PTR1
                                 1e5                                                                    WT        cDKO        SKO       cDKO         cDKO cDKO
                                10000                                                                             + TET                 -TET         -TET -TET
                                                                                                                                        Day 2        Day 4 Day 6
                                1000

                                 100

                                        0   2     4          6   8
                                                Time, days

                                                                 C                      180

                                                                                        160

                                                                                        140
                                                                 Thiols,   control




                                                                                        120

                                                                                        100

                                                                                        80

                                                                                        60

                                                                                        40

                                                                                        20

                                                                                         0

                                                                                              0          2                4
                                                                                                     Time, days

Fig. 2. Growth characteristics biochemical analysis cDKO cells vitro.  growth cDKO cell line HMI9-T media monitored presence (closed circles) absence tetracycline (open circles,
dashed line). arrow indicates point viable cells longer recoverable subcultured 10 days medium
containing tetracycline.
B. Immunoblots cell extracts WT, SKO cDKO (plus minus tetracycline) cells probed antiserum T. brucei TRYS T. brucei PTR1 control (1 Â¥ 107 parasites lane).
C. Intracellular T[SH]2 (closed circles) GSH (open circles) levels cDKO cells following removal tetracycline cultures. Initial
levels T[SH]2 GSH untreated cells 0.42 0.54 nmol(108 cells)-1 respectively. data point represents means â«¾ standard deviations triplicate determinations.


maintain expression ectopic TRYS. Infections                                                     mutants essential genes T. brucei (Chang et al.,
monitored 30 day period survival curves                                                    2002; Roper et al., 2002). Collectively, results infection shown Fig. 3. Mice infected WT                                                confirm TRYS essential parasite survival parasites succumbed infection day 5                                                   mammalian host. case mice infected cells expressing
ectopic TRYS (cDKO plus doxycycline). contrast,                                                                                                          Chemical validation TRYS drug target mice infected cDKO cells absence                                                                                                          T. brucei
doxycycline remained completely free parasites 30 days remaining mouse                                                       Genetic validation crucial step identification
group showed lethal parasitaemia day 23.                                                       drug target.  importance demonstrat-
Western blot analysis cells recovered infected                                              ing target â€˜druggableâ€™ cell mouse confirmed parasites regained                                                        underestimated. result high-throughput drug
expression TRYS, suggesting tetracycline control                                                 screening medicinal chemistry campaign carried lost, common phenomenon conditional null                                                   Drug Discovery Unit Dundee, DDU 86439 (N-(3-

                                                                                                                                      Â© 2009 Authors
                                                                 Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
                                                                                           Synthetase amidase activity TRYS essential 533

                                                                       (14 mM) maintain 5  original
                   100                                                 T[SH]2 levels 72 h. case cDKO cells
                                                                       (Fig. 2B), absence functional TRYS drug-treated
                                                                       cells led accumulation GSH, levels reaching
                    80                                                 fourfold higher seen untreated cells.                                                                        greater speed magnitude effects consis-
     Survival,  




                                                                       tent acute effects chemical inhibition compared
                    60
                                                                       slower effects loss target activity genetic
                                                                       intervention (Fig. 2D). observations suggest
                    40                                                 minimum concentration T[SH]2 compatible                                                                        survival ~3 mM [Table S3, assuming 108 cells = 5.8 ml
                                                                       (Opperdoes et al., 1984)].
                    20

                                                                       amidase activity TRYS essential                      0                                                 bloodstream T. brucei?
                         0   10             20             30
                                                                       Following unequivocal chemical genetic valida-
                                  Time, days
                                                                       tion synthetase activity TRYS drug target Fig. 3. Virulence cDKO parasites mice. Groups mice       bloodstream T. brucei, posed question: infected WT cDKO cells (1 Â¥ 104 parasites).        bifunctional enzyme actually embody drug targets Mice infected tetracycline-treated parasites dosed                                                                         Comparatively little known amidase
doxycycline drinking water 3 days prior   infection. Data presented form Kaplanâ€“Meier        activity TRYS biological function remains
survival plot. Symbols: WT, blue; cDKO presence              unclear. previous kinetic structural studies, cys-
doxycycline, red; cDKO absence doxycycline, green.
                                                                       teine position 59 equivalent Crithidia fasiculata
                                                                       (Oza et al., 2002a) L. major (Fyfe et al., 2008)
(dimethylamino)propyl)-2-(3-(3-fluorophenyl)-1H-indazol-               enzymes demonstrated critical cata-
1-yl)acetamide, Fig. 4A) identified potent inhibi-            lytic mechanism TRYS-amidase. Replacement tor recombinant T. brucei TRYS IC50 45 nM                cysteine 59 alanine Crithidia enzyme
 details published . com-                resulted functional synthetase devoid amidase
pound inhibited growth WT cells HMI9-T media                 activity. determine role TRYS-amidase para- EC50 value 7.0 â«¾ 0.2 mM following 72 h                    site viability virulence, knowledge exploited
exposure. confirm TRYS specifically targeted               generate TRYS conditional null mutant cell line compound, TRYS SKO overexpressing (OE)                     (cDKO(C57A)) expressing amidase-â€˜deadâ€™ enzyme
cell lines compared WT cells relative              tetracycline control (Fig. S3).
sensitivity compound DDU 86439. Western analysis                       amidase dead cell line viable HMI9-T densitometry demonstrated TRYS protein levels                 medium presence tetracycline generation approximately twofold lower SKO cells (Fig. 2B)                time 11.1 â«¾ 0.1 h (Fig. 5A), marginally slower threefold higher OE cells compared WT                   original cDKO line (9.9 â«¾ 0.02 h). Removal tetracycline
levels (Fig. S2). Changes level TRYS                resulted slow death parasites 8 day
cells correlated relative sensitivity com-          period viability lost day 6 culture, 
pound DDU 86439 EC50 values 1.2 â«¾ 0.04                     firming TRYS synthetase, amidase activity 23.0 â«¾ 0.4 mM SKO OE cell lines respectively                   essential growth vitro. identical manner (Fig. 4B). cDKO cells, grown absence tetracy-                cDKO cell line, intracellular T[SH]2 levels fell following cline 2 days prior analysis, hyper-            removal tetracycline cDKO(C57A) cultures sensitive compound (EC50 0.46 â«¾ 0.01 mM,                       GSH steadily accumulated (Fig. 5B). Parasites express-
Fig. 4B), providing evidence TRYS spe-             ing amidase-dead TRYS markedly virulent
cific target inhibitor.                                        mice expressing functional enzyme
   Intracellular thiol levels determined WT para-              (Fig. 5C). mice infected cDKO(C57A) gradu-
sites following incubation concentrations TRYS             ally succumbed infection 9 day period, day
inhibitor corresponding 0.5, 1.0, 1.5 2.0 times             6â€“15, cDKO-infected animals died day 5. established EC50 value (7 mM) (Fig. 4C). Treatment                parasites recovered cDKO(C57A)-infected mice 
DDU 86439 resulted significant, dose-dependent                    tinued express mutated form TRYS enzyme,
decrease levels intracellular T[SH]2. Trypano-               determined PCR sequence analysis genomic
somes incubated highest levels compound               DNA (data shown). mice infected 
Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
 534 S. Wyllie et al. äŠ?

                                                             



               B                                                            C
                               100                                                              400


                               80
                                                                                                300




                                                                            Thiols,   control
               Cell count,  




                               60

                                                                                                200
                               40


                                                                                                100
                               20



                                0                                                                 0
                                     0.1   1         10          100                                  0   0.5           1         1.5   2
                                           [Inhibitor], Î¼M                                                      Inhibitor, fold EC50


                                                                                                      0   3.5           7        10.5   14
                                                                                                                [DDU 86439], Î¼M

Fig. 4. Chemical targeting TRYS T. brucei.  Chemical structure TRYS inhibitor DDU 86439 (N-(3-(dimethylamino)propyl)-2-(3-(3-fluorophenyl)-1H-indazol-1-yl)acetamide).
B. EC50 values determined DDU 86439 WT (closed circles), SKO (open squares), TRYS-overexpressing (open circles) cDKO cells grown absence tetracycline 2 days prior analysis (closed squares, dotted line). curves non-linear fits data using parameter EC50 equation provided GraFit  Experimental procedures). EC50 values 7.1 â«¾ 0.2, 1.2 â«¾ 0.05, 23.3 â«¾ 0.3 0.46 â«¾ 0.01 mM determined WT, SKO, TRYS-overexpressing cDKO cell lines respectively. Data mean duplicate
measurements.
C. Analysis intracellular T[SH]2 (closed circles) GSH (open circles) levels T. brucei bloodstream parasites (WT) following incubation compound DDU 86439 (72 h). Data represented percentage thiol levels untreated cells (0.51 0.42 nmol(108 cells)-1 GSH T[SH]2 respectively; Table S1) measurement mean individual measurements.


cDKO(C57A) cells absence doxycycline                               logical function remains. researchers remained free parasites 20 days                      suggested ability hydrolyse T[SH]2 com- terminally infected, mouse remained                       ponents, GSH spermidine enable cells parasite-free entire 30 days experiment.                      respond conditions polyamine deprivation (Oza
Western PCR analysis parasites recovered                         et al., 2002b; Fyfe et al., 2008). examine hypoth- infected animals revealed tetracycline control                  esis, cDKO cDKO(C57A) cell lines tested lost mutated TRYS                          relative sensitivity difluoromethylornithine
freely expressed (data shown). evident                  (DFMO) (Fig. 6A), suicide inhibitor ornithine decar-
TRYS-amidase activity essential vivo                 boxylase, rate-determining enzyme polyamine bio-
vitro viability T. brucei, absence activity                   synthesis (Phillips Wang, 1987; Phillips et al., 1988).
retards growth vitro decreases virulence                       primary role TRYS-amidase release
mouse model.                                                                 polyamine stores T[SH]2 times need,                                                                              reasonable assume cells ability
                                                                             sensitive DFMO.  cell biological function TRYS-amidase                                                                              line expressing functional TRYS-amidase just
T. brucei?
                                                                             sensitive DFMO cell line expressing TRYS-amidase required viability viru-                   â€˜deadâ€™ enzyme (EC50: 17.5 â«¾ 0.5 16.6 â«¾ 0.8 mM
lence bloodstream T. brucei, question bio-                     respectively).

                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
                                                                                                                                                                        Synthetase amidase activity TRYS essential 535

                                                                                               B                                                                         C
                                                                                                                     180
                                 1e10
                                                                                                                     160                                                                 100
                                  1e9
Cumulative cell numbers, ml-1




                                                                                                                     140
                                  1e8                                                                                                                                                     80
                                                                                                                     120




                                                                                                 Thiols,   control




                                                                                                                                                                           Survival,  
                                  1e7
                                                                                                                     100
                                                                                                                                                                                          60
                                  1e6                                                                                 80

                                  1e5                                                                                 60                                                                  40

                                10000                                                                                 40
                                                                                                                                                                                          20
                                 1000                                                                                 20

                                                                                                                       0
                                  100
                                                                                                                                                                                             0
                                        0                   2          4          6     8                                  0       2                           4                                 0           10            20   30
                                                                     Time, days                                                  Time, days                                                                       Time, days

Fig. 5. vitro vivo characterization TRYS-amidase â€˜deadâ€™ cell line.  growth cDKO(C57A) cell line HMI9-T medium monitored presence (closed circles) absence tetracycline
(open circles, dashed line) arrow indicates point viable cells longer recoverable subcultured 10 days medium containing tetracycline.
B. Intracellular T[SH]2 (closed circles) GSH (open circles) levels cDKO(C57A) cells following removal tetracycline cultures. data point represents means â«¾ standard deviations triplicate determinations.
C. Groups mice infected WT cDKO(C57A) cells (1 Â¥ 104 parasites). Mice infected tetracycline-treated parasites dosed doxycycline drinking water 3 days prior   infection. Data presented form Kaplanâ€“Meier survival plot. Symbols: WT, blue; cDKO presence doxycycline, red; cDKO absence doxycycline, green.


  determine reduced virulence                                                                                    shown dosing mice manner increased
cDKO(C57A) cell line attributed inability                                                                            parasite polyamine levels extent DFMO
access T[SH]2-conjugated polyamines, groups                                                                                         longer cure infection (McCann et al., 1981;
cDKO(C57A)-infected mice given daily bolus                                                                                   Nathan et al., 1981). Similarly, hypothesized spermidine intraperitoneal injection. Previous studies                                                                             increased polyamine levels cDKO(C57A) cells 

                                                                                                                                     B
                                                            100                                                                                      100



                                                                80                                                                                   80
                                            Cell count,  




                                                                                                                                       Survival,  




                                                                60                                                                                   60



                                                                40                                                                                   40



                                                                20                                                                                   20



                                                                0                                                                                     0
                                                                           1                10                             100                             0   1   2   3                 4       5   6   7        8   9   10
                                                                                      [DFMO], Î¼M                                                                                         Time, days

Fig. 6. effect polyamines growth virulence cDKO(C57A) parasites.  EC50 values determined DFMO cDKO (closed circles) cDKO(C57A) cells (closed circles). curves non-linear fits data using parameter EC50 equation provided GraFit  Experimental procedures). EC50 values 17.5 â«¾ 0.5 16.6 â«¾ 0.8 mM determined cDKO cDKO(C57A) cell lines respectively. Data mean duplicate measurements.
B. Groups mice infected cDKO cDKO(C57A) cells (1 Â¥ 104 parasites). mice infected tetracycline-treated
parasites dosed doxycycline drinking water. set cDKO cDKO(C57A)-infected mice received daily
intraperitoneal injections spermidine (100 mg kg-1). Data presented form Kaplanâ€“Meier survival plot. Symbols: cDKO, blue;
cDKO plus spermidine, red; cDKO(C57A), green; cDKO(C57A) plus spermidine, yellow.

Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
 536 S. Wyllie et al. äŠ?

result return levels virulence seen cDKO          high metabolic turnover. Given infections. Mice inoculated cDKO cell line suc-            existing drugs interact directly indirectly T[SH]2
cumbed infection days 4 5, regardless              metabolism (Fairlamb, 2003), inhibitors TRYS presence absence additional spermidine (Fig. 6B).             prove ideal candidates combination therapy. RNAi  cDKO(C57A) parasites virulent             studies revealed TRYS-depleted T. brucei pro- expressing functional TRYS-amidase,               cyclics significantly susceptible trypanocides,
mice heavily infected days 6 10.               melarsoprol triostam, known act significantly, daily dosing infected mice sper-        T[SH]2 metabolism (Ariyanayagam et al., 2005). addi-
midine absolutely effect virulence             tion, procyclics sensitive cDKO(C57A) cells. failure additional spermidine           redox-cycling drug nifurtimox, currently phase III clinical
enhance virulence cells suggest             trials use African sleeping sickness. Collec- primary function TRYS-amidase enable               tively, findings suggest use drugs target-
access T[SH]2-conjugated polyamines.                             ing TRYS, combination existing drugs, prove
   findings bring question hypothesis           effective strategy treating T. brucei infections.
TRYS-amidase plays pivotal role regulation cellular polyamines (Shim Fairlamb, 1988; Tetaud
et al., 1998; Oza et al., 2002b; Fyfe et al., 2008).                                                                     Experimental procedures case, biological function           Cell lines culture conditions
amidase T. brucei? Kinetic analysis recombinant
                                                                    Trypanosoma brucei bloodstream-form â€˜single markerâ€™ S427
T. brucei T. cruzi TRYS shown amidase
                                                                    (T7RPOL TETR NEO) knockouts cultured 37Â°C
activity enzymes equivalent 1                                                                      modified HMI9 medium (56 mM 1-thioglycerol substi- synthetase activity optimal assay conditions              tuted 200 mM 2-mercaptoethanol) supplemented (Oza et al., 2002b; 2003). true          2.5 mg ml-1 G418 maintain expression T7 RNA poly- vivo enzyme, difficult amidase        merase tetracycline repressor protein (Hirumi meaningful impact intracellular polyamine               Hirumi, 1989). Cultures initiated 1 Â¥ 105 cells ml-1
levels. Alternatively, low enzymatic activity recom-         subcultured cell densities approached
binant TRYS-amidase readily explained T[SH]2            1â€“2 (Â¥ 106) ml-1. Single marker (WT), SKO, cDKO OE
                                                                    cell lines grown continuously presence GspdSH natural substrates                                                                     appropriate drug selection  details).
enzyme. Gram-positive bacteria Mycobacterium                    order examine effects inhibitors growth smegmatis, thiol S-conjugate amidase char-               parasites, triplicate cultures containing inhibitor
acterized specifically hydrolyses thiol-conjugated            seeded 1 Â¥ 105 trypanosomes ml-1. Cell densities
xenobiotics, resulting detoxification xenobiotic          determined using CASY Model TT cell counter recycling thiol (Newton et al., 2000). tempt-      (SchÃ¤rfe) culture 72 h. EC50 values determined
ing suggest TRYS-amidase play similar role            using following parameter equation non-linear
                                                                    regression using GraFit: T. brucei enzyme highly selective S-conjugates T[SH]2 formed trypanothione                                                       100
                                                                                           y=
                                                                                                        âŽž
                                                                                                            m
S-transferase (Vickers Fairlamb, 2004). Studies                                                                                                 1+ âŽ›
underway test validity hypothesis.                                          âŽ? EC50 âŽ 
irrefutable study TRYS-amidase           experimental data corrected background
viable drug target African trypanosome.                      cell density expressed percentage uninhibited
                                                                    control cell density. equation   represents inhibitor
                                                                    concentration m slope factor.
Implications parasite chemotherapy
 study, TRYS chemically genetically
                                                                    Generation knockout, overexpression recovery
validated drug target bloodstream T. brucei.                                                                     constructs shown TRYS null trypanosomes unable establish infection mice chemical targeting          primers used summarized Table 1 enzyme leads parasite death. potency          designed using T. brucei trypanothione synthetase
lead TRYS inhibitor bloodstream trypanosomes                (TRYS) sequence GeneDB (Tb927.2.4370) template.
                                                                    accuracy assembled constructs verified (EC50 7 mM) compares favourably eflornithine
                                                                    sequencing. TRYS gene replacement cassettes gener-
(EC50 17.5 mM, Fig. 6A), current line drug used                                                                     ated amplifying region DNA encompassing treatment HAT. Like eflornithine, DDU 86439           5â€²-UTR, open reading frame (ORF) 3â€²-UTR T. brucei
rapidly cidal decrease intracellular T[SH]2              TRYS genomic DNA primers 5â€²UTR-NotI_s content compatible dilution cell division            3â€²UTR-NotI_as, using Pfu polymerase. sequence 
                                                                                                                Â© 2009 Authors
                                           Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
                                                                                                Synthetase amidase activity TRYS essential 537

Table 1. Upper case letters refer nucleotides corresponding gene sequences T. brucei; lower case refers additional sequences used generating constructs.

Primer                                     Primer sequence

5â€²UTR-NotI_s                                    5â€²-ataagaatgcggccgcTGTGGTTGTTGTTTC-3â€²
5â€²UTR-HindIII/PmeI_as                           5â€²-gtttaaacttacggaccgtcaagcttTTGTTTCAATTGCTTTTCC-3â€²
3â€²UTR-PmeI/BamHI_s                              5â€²-gacggtccgtaagtttaaacggatccCACAACCCTTCCGTTTTG-3â€²
3â€²UTR-NotI_as                                   5â€²-ataagtaagcggccgcGGAATAAACATAAAGC-3â€²
TbTRYS-HindIII_s                                5â€²-cggaaggagaaagcttatgggcagcagccat-3â€²
TbTRYS-BamHI_as                                 5â€²-ggatccCTACATTTGAATACGTACGGGACCAAACGGAGATTCGAGCCCAGTGATGAGCTT-3â€²
TbTRYS(C57A) mut_s                              5â€²-cttttctgcggtttcaaataccaagctgtagaattt-3â€²
TbTRYS(C57A) mut_as                             5â€²-aaattctacagcttggtatttgaaaccgcagaaaag-3â€²

Restriction endonuclease sites underlined mutations used generate amidase-dead TRYS indicated bold.



 used template amplification individual          pLew100_TbTRYS mutated version vector
regions used assembly replacement cassettes                pLew100_TbTRYS(C57A) cultured presence taining selectable drug-resistance genes puromycin                   2.5 mg ml-1 blasticidin addition puromycin. Prior N-acetyl transferase (PAC) hygromycin phosphotrans-                  removal remaining TRYS allele, expression ferase (HYG), exactly previously described (Martin                recombinant TRYS proteins induced addition Smith, 2005).                                                            tetracycline (2 mg ml-1, 72 h) culture medium. cDKO
   generate recovery construct pLew100_TbTRYS,                cell line finally generated following replacement TRYS ORF T. brucei amplified genomic DNA                   final TRYS allele HYG. resulting cell line using TbTRYS-HindIII sense TbTRYS-BamHI antisense                    cultured presence hygromycin (4.0 mg ml-1) primers, cloned pCR-Blunt II TOPO (Invitrogen).             addition previously described drugs. TRYS
pCR-Blunt II-TOPO-TbTRYS construct digested                     overexpression cell line generated directly trans- HindIII BamHI resulting fragment ligated           forming single marker bloodstream parasites HindIII/BamHI cloning site modified pLew100                     pLew100_TbTRYS vector inducing recombinant protein
tetracycline-inducible expression vector (Wirtz et al., 1999)            expression addition tetracycline. step contains blasticidin S transferase (BSD) select-            generation transgenic cell lines, parasites able gene marker (kindly supplied Dr Kirstee Martin).             cloned serial dilution.
resulting rescue vector used TRYS overex-
pression vector single marker T. brucei bloodstream
parasites.                                                               Southern blot analyses transgenic T. brucei cell lines
   additional recovery construct generated containing mutated version T. brucei TRYS gene. Site-directed              ORF T. brucei TRYS amplified PCR (using mutagenesis carried following QuikChangeÂ® pro-               primers previously described cloning TbTRYS tocol (Stratagene) using KOD HotStart DNA poly-                  pLew100-BSD) PCR DIG Probe Synthesis Kit
merase (Novagen). Using pLew100_TbTRYS construct                     (Roche). resulting digoxigenin-labelled TbTRYS product template, C mutation introduced position 57           used probe. Samples genomic DNA (5 mg) T. brucei TRYS generated PCR resulting                  single marker transgenic cell lines digested modified construct â€“ pLew100_TbTRYS(C57A).                               restriction endonuclease PstI, digestion products                                                                          separated 0.8  agarose gel transferred                                                                          positively charged nylon membrane (Roche). mem-
Generation transgenic T. brucei cell lines                            brane hybridized overnight DIG Easy Hyb solution
                                                                         (Roche) 42Â°C DIG-labelled TRYS ORF probe (2 ml
Knockout, recovery overexpression constructs pre-               PCR product). Following hybridization, membranes pared using QIAprep Miniprep Plasmid Kit (Qiagen). DNA                   washed twice low stringency conditions (25Â°C, 2 Â¥ 5 min, digested NotI, ethanol precipitated redissolved             2Â¥ SSC 0.1  SDS) twice high stringency condi- sterile water final concentration 1 mg ml-1. Trypano-         tions (68Â°C, 2 Â¥ 15 min, 0.5Â¥ SSC 0.1  SDS), 1Â¥
somes electroporated 5 mg DNA using reagents                SSC comprises 150 mM sodium chloride 50 mM sodium Human T cell Nucleofector kit manufacturersâ€™             acetate, pH 7.0. Bound probe detected using DIG
instructions using programme X-001 Nucleofector               immunological detection kit (Roche) manufacturersâ€™
II electroporator (Amaxa, Cologne, Germany) (Burkard et al.,             instructions.
2007).
   cDKO TRYS generated sequentially replac-
ing endogenous TRYS genes drug-resistance genes.                Western blot analysis T. brucei cell lysates TRYS allele replaced drug-resistance
gene PAC resulting SKO cell line cultured              Polyclonal antisera T. brucei TRYS raised continuous presence 0.1 mg ml-1 puromycin. SKO                adult male Wistar rats. initial injection 100 mg purified
cells transformed recovery vector              antigen, emulsified complete Freundâ€™s adjuvant, fol-

Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
 538 S. Wyllie et al. äŠ?

lowed identical booster injections antigen emulsified     vivo studies Freundâ€™s incomplete adjuvant 2 week intervals.
   Trypanosoma brucei cell extracts (1 Â¥ 107 parasites        Wild-type transgenic bloodstream T. brucei parasites lane) separated SDS/PAGE subsequently               cultured absence selectable drugs (hygromy-
transferred nitrocellulose. blocking 7              cin, blasticidin, puromycin G418) 24 h prior infec-
skimmed milk phosphate buffered saline (PBS) 1 h,            tion mice. time, cDKO cells grown blots incubated T. brucei TRYS (1:700 dilu-        presence absence 1 mg ml-1 tetracycline. para-
tion) T. brucei PTR1 (1:500) (Sienkiewicz et al., 2008)          sites used infect groups mice (dosed polyclonal antiserum 1 h, washed PBS containing 0.1          doxycycline respectively) single intraperito-
(v/v) Tween-20, incubated secondary anti-           neal injection 104 parasites 0.2 ml HMI9-T medium.
body [rabbit anti(rat IgG)] (Dako, Ely, UK; 1:10 000 dilution).     plus doxycycline group animals dosed doxy-
Immunoblots developed using ECL plus (enhanced             cycline drinking water (0.2 mg ml-1 5  sucrose
chemiluminescence) GE Healthcare (Piscat-               solution) 5 days prior infection freshly prepared
away, NJ, USA).                                                     second day duration experiment. Animals
                                                                    inspected daily clinical signs infection wet
                                                                    smears tail blood examined microscopically. Parasi-
Drug discovery                                                      taemia determined using Neubauer haemocytometer,
                                                                    previously described (Sienkiewicz et al., 2008). Mice high-throughput screening campaign 63 000 compounds            exceeded parasitaemia > 108 ml-1 humanely killed,
led identification novel chemical classes      prior experience indicated animals T. brucei TRYS inhibitor. Chemical development               succumb overwhelming infection following day. lead compounds led identification com-
pound DDU 86439 (N-(3-(dimethylamino)propyl)-2-(3-(3-
fluorophenyl)-1H-indazol-1-yl)acetamide) (patent pending)           Acknowledgements inhibited recombinant TRYS potency 0.045 mM inhibited growth bloodstream trypano-           appreciation goes Adel Ibrahim University
somes EC50 6.9 â«¾ 0.2 mM. DDU 86439 pre-              Dundee Cloning Service help site-directed
pared synthetic steps indazole. Briefly, indazole      mutagenesis cloning pLew100 Dr Natasha Sien- iodinated position, previously described        kiewicz helpful advice concerning generation trans-
(Edwards et al., 2003). resultant aryl iodide served            genic organisms. thank Dr Paul Wyatt, Director substrate Suzuki coupling reaction                Dundee Drug Discovery Unit invaluable advice 3-fluorophenylboronic acid analogous manner           medicinal chemistry presented paper. work previously described (El Kazzouli et al., 2005). indazole       funded grants Wellcome Trust (WT 079838; WT N 1-alkylated treatment sodium hydride         077705; WT 083481).
ethyl bromoacetate. resulting crude ester hydro-
lysed treatment sodium hydroxide water/
tetrahydrofuran. Following acidic workup, product               References
carboxylic acid purified silica column chromatography. amide synthesis accomplished standard carbo-            Alibu, V.P., Richter, C., Voncken, F., Marti, G., Shahi, S.,
diimide chemistry utilizing N-(3-Dimethylaminopropyl)-                 Renggli, C.K., et al. (2006) role Trypanosoma brucei
Nâ€²-ethylcarbodiimide,        1-Hydroxybenzotriazole,      N,N-         MRPA melarsoprol susceptibility. Mol Biochem Parasitol
Diisopropylethylamine 3-(dimethylamino)-1-propylamine              146: 38â€“44. furnish title compound, purified silica         Ariyanayagam, M.R., Fairlamb, H. (2001) Ovothiol column chromatography. details chemical synthesis           trypanothione antioxidants trypanosomatids. Mol inhibitors published                Biochem Parasitol 115: 189â€“198.
                                                                    Ariyanayagam, M.R., Oza, S.L., Guther, M.L., Fairlamb,
                                                                       H. (2005) Phenotypic analysis trypanothione syn-
Analysis intracellular thiols                                       thetase knockdown African trypanosome. Biochem J
                                                                       391: 425â€“432. determine effect inhibitor DDU 86439 intracellu-       Bacchi, C.J., Yarlett, N. (1995) Polyamine metabolism. lar thiol levels, cultures containing 1 Â¥ 105 bloodstream trypa-       Biochemistry Molecular Biology Parasites. Marr,
nosomes ml-1 incubated varying concentrations             J.J., MÃ¼ller, M. (eds). London: Academic Press, pp.
inhibitor DDU 86439 equivalent 0.5, 1.0, 1.5 2Â¥             119â€“131.
previously determined EC50 (6.9 â«¾ 0.2 mM). Following incuba-        Barrett, M.P., Fairlamb, H. (1999) biochemical
tion 72 h, cells (1 Â¥ 108) collected centrifugation        basis arsenical-diamidine cross-resistance African
(900 g, 10 min, 4Â°C), washed ice-cold PSG buffer               trypanosomes. Parasitol Today 15: 136â€“140.
(PBS, pH 8.0, 1.5  (w/v) glucose 0.5 mg ml-1 BSA)           Bateman, , Rawlings, N.D. (2003) CHAP domain: derivatised monobromobimane, described previously              large family amidases including GSP amidase pep-
(Shim Fairlamb, 1988). Acid-soluble thiols sepa-              tidoglycan hydrolases. Trends Biochem Sci 28: 234â€“237.
rated ion-paired, reverse phase HPLC ion-paired            Burkard, G., Fragoso, C.M., Roditi,  (2007) Highly effi-
Ultrasphere C18 column using Dionex Ultimate 3000 instru-            cient stable transformation bloodstream forms Trypa-
ment fitted Dionex RF-2000 fluorometer.                         nosoma brucei. Mol Biochem Parasitol 153: 220â€“223.

                                                                                                                Â© 2009 Authors
                                           Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 74, 529â€“540
                                                                                        Synthetase amidase activity TRYS essential 539

Chang, T., Milne, K.G., Guther, M.L.S., Smith, T.K.,              Nathan, H.C., Amole, B.O., et al. (1981) studies   Ferguson, M J. (2002) Cloning Trypanosoma brucei               difluoromethylornithine African trypanosomes. Med Biol
  Leishmania major genes encoding GlcNAc-                     59: 434â€“440.
  phosphatidylinositol n-acetylase glycosylphosphati-         Martin, K., Smith, T.K. (2005) myo-inositol-1-
  dylinositol biosynthesis essential african           phosphate synthase gene essential Trypanosoma
  sleeping sickness parasite. J Biol Chem 277: 50176â€“                 brucei. Biochem Soc Trans 33: 983â€“985.
  50182.                                                            Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J.,
Comini, M , Guerrero, S , Haile, S., Menge, U., Lunsdorf,         Ouellette, M., Rosen, B.P. (1996) Trypanothione 
  H., FlohÃ©, L. (2004) Validation Trypanosoma brucei           production resistance antimonials arsenicals   trypanothione synthetase drug target. Free Radic Biol            Leishmania. Proc Natl Acad Sci USA 93: 10383â€“10387.
  Med 36: 1289â€“1302.                                                Nathan, H.C., Bacchi, C.J., Hutner, S.H., Rescigno, D., Croft, S.L., Sundar, S., Fairlamb, H. (2006) Drug               Sjoerdsma,  (1981) Antagonism polyamines   Resistance Leishmaniasis. Clin Microbiol Rev 19: 111â€“            curative effects difluoromethylornithine Trypano-
  126.                                                                soma brucei brucei infections. Biochem Pharmacol 30:
Dormeyer, M., Reckenfelderbaumer, N., Ludemann, H.,               3010â€“3013.
  Krauth-Siegel, R.L. (2001) Trypanothione-dependent syn-           Newton, G.L., Av-Gay, Y., Fahey, R.C. (2000) novel
  thesis deoxyribonucleotides Trypanosoma brucei                mycothiol-dependent detoxification pathway mycobacte-
  ribonucleotide reductase. J Biol Chem 276: 10602â€“10606.             ria involving mycothiol S-conjugate amidase. Biochemistry
Edwards, M.L., Cox, P.J., Amendola, S., Deprets, S.D.,                39: 10739â€“10746.
  Gillespy, T , Edlin, C.D., et al. (2003) Benzimidazoles         Opperdoes, F.R., Baudhuin, P., Coppens, , Roe, C.,
  analogues use protein kinases inhibitors.          Edwards, S.W., Weijers, P.J., Misset, O. (1984) Puri-
  Aventis Pharmaceuticals  Patent WO/2003/035065.                 fication, morphometric analysis, characterization El Kazzouli, S., Bouissane, L., Khoulli, M., Guillaumet, G.       glycosomes (microbodies) protozoan hemoflagellate
  (2005) Synthesis 4-substituted 3,4-disubstituted             Trypanosoma brucei. J Cell Biol 98: 1178â€“1184.
  indazole derivatives palladium-mediated cross-coupling         Oza, S.L., Ariyanayagam, M.R., Fairlamb, H. (2002a)
  reactions. Tetrahedron Lett 46: 6163â€“6167.                          Characterization recombinant glutathionylsper